Myriad Genetics Inc (NASDAQ:MYGN)

16.05
Delayed Data
As of Sep 29
 -0.74 / -4.41%
Today’s Change
13.92
Today|||52-Week Range
24.21
+10.61%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Diaz Paul J
President & Chief Executive Officer
Sale8/13/202351,292$17.89$917.6K-9.94%
Diaz Paul J
President & Chief Executive Officer
Sale3/24/202326,997$23.72$640.4K-32.38%
Diaz Paul J
President & Chief Executive Officer
Sale3/22/202320,046$22.91$459.3K-29.99%
Diaz Paul J
President & Chief Executive Officer
Sale3/24/202318,428$23.72$437.1K-32.38%
Diaz Paul J
President & Chief Executive Officer
Sale8/13/202322,943$17.89$410.5K-9.94%
Riggsbee R Bryan
Chief Financial Officer
Sale3/02/202315,000$22.55$338.3K-29.96%
Riggsbee R Bryan
Chief Financial Officer
Sale12/27/202220,000$15.15$303.0K+4.36%
Lambert Nicole
Chief Operating Officer
Sale3/02/202313,184$22.74$299.8K-29.96%
Riggsbee R Bryan
Chief Financial Officer
Sale2/18/202311,222$19.42$217.9K-11.77%
Spiegelman Daniel K
Director
Sale6/02/20238,638$23.01$198.8K-31.54%
Page of 8